First-ever Treatment Approved for Smoldering Myeloma Comes With Questions
Doctors urge patients to weigh benefits and risks after the FDA approved a treatment for high-risk smoldering myeloma.
Practical Knowledge
Doctors urge patients to weigh benefits and risks after the FDA approved a treatment for high-risk smoldering myeloma.
The editors of Cancer Today share impactful reporting and writing on cancer research and care from 2025.
Research suggests finding blood in stool is often an indicator of colorectal cancer.
Products containing biotin can alter lab tests for people during and after cancer treatment.
AACR conference brings experts together to discuss strategies to reach people historically left out of cancer research.
Multiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
At a defining moment, a broad coalition will come to Capitol Hill to protect science, defend progress and stand up for patients. Congress must hear from you next.
Experts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
In every issue, Cancer Today offers information and inspiration as readers face the challenges of diagnosis, treatment, survivorship, or caregiving. Cancer Today subscriptions are free to cancer patients, survivors, caregivers, and others in the United States.
Subscribe Today